Dotmatics Ltd

Dotmatics has licensed its browser & gateway suite to Addex Pharmaceuticals, a drug discovery and development company.

2008-04-04T07:49:00Z

Bishop’s Stortford, 4^th April 2008 – Scientific software company Dotmatics is pleased to announce that Addex Pharmaceuticals SA (Addex) has licensed the Dotmatics web-based browser & gateway suites to facilitate information access and project management. The solution will be used by Addex to query, browse, analyse and share key drug discovery information across research programs and project teams.

Dotmatics’ browser & gateway solutions offer the following advantages:

· The use of a true zero-client web based approach is compatible with our clients’ service oriented architecture approach to enable real-time access to information and additionally reduces any IT support overhead.

· The ability to integrate with pre-existing informatics tools (based on legacy informatics platforms) such as ELN, chemical & biological databases and inventory management.

· The easy-to-use interface allows scientists to make the most of the powerful querying, visualisation and analysis capabilities of the tools, with minimal training.

Eric Gaillard, head of IT at Addex said: “The research process at Addex is dynamic, involving multiple internal and external groups. Part of my mission is to deliver on-demand real-time access to the latest incoming research information to managers. The Dotmatics gateway and browser complement our core research informatics framework and enable me to achieve this level of service.”

Steve Gallagher, CEO of Dotmatics said: “We are excited to have the opportunity to work with Addex Pharmaceuticals and look forward to a fruitful collaboration.”

About Dotmatics

Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, browsed, managed and shared within companies. Dotmatics has significant expertise in cheminformatics techniques including chemical databases, SAR analysis, data management and data visualization. A privately-owned company, Dotmatics was founded in 2005 and is based south of Cambridge, UK.

Browser is a querying, browsing and visualising tool for biological and chemical datasets.

Gateway is a centralised depot for sharing information both internally within a company and externally with collaborators.

For further information please visit www.dotmatics.com.

Contact for Dotmatics Limited:

Jean Mercier

Sales & Marketing Director

Dotmatics Ltd

+44 (0)1279 654 123

jm@dotmatics.com

dotmatics announce new premises

2007-10-15T07:27:00Z

Bishops Stortford, United Kingdom, October 15th 2007 - dotmatics, a provider of information and data management solutions to the life sciences industry, is pleased to announce that on the 24th September 2007 it moved into its new offices.

Stephen Gallagher, Chief Executive Officer of dotmatics said, "Moving the company to new premises allows us to continue to expand our support and development capability."

dotmatics is exhibiting at Drug Discovery & Development of Innovative Therapeutics

2007-07-27T10:11:00Z

Visit us at the Drug Discovery & Development of Innovative Therapeutics in Boston (6-9 Aug). We will be exhibiting at booth #310.

Dotmatics joins BioIT Alliance community

2007-07-27T10:10:00Z

dotmatics has joined the Microsoft’s BioIT Alliance community. The BioIT Alliance is a cross-industry group working to integrate science and technology to accelerate the pace of drug discovery and realize the potential of personalized medicine.

"Our customers are looking for solutions that enable them to aggregate many forms of complex information and navigate through it effectively" said Don Rule, Platform Strategy Advisor for Bioinformatics at Microsoft. "We look forward to working with Dotmatics to provide scientists with richer and more integrated solutions."

Waters Corporation and dotmatics to collaborate

2007-07-27T10:08:00Z

Waters Corporation (NYSE:WAT) and dotmatics have signed an agreement to develop integrated advanced structure elucidation software to complement Waters time-of-flight (Tof) mass spectrometers and the Waters® Synapt™ and MALDI Synapt High Definition Mass Spectrometry™ (HDMS) Systems. The agreement will focus on developing a fully-integrated solution for structural elucidation of small molecules based on Dotmatics and Waters MassLynx™ MetaboLynx™ Application Manager software.

"We are pleased to provide researchers with a fully integrated software package which is compatible with our innovative LC/MS/MS and LC/MS E data acquisition strategies that will allow scientists to interrogate fragmentation rich spectra and reduce the bottleneck in deciphering important molecular structures. The combination of Synapt HDMS System and this important collaboration will provide researchers with advanced tools for small molecule profiling," said Dr. Tim Riley, Vice-President and Managing Director, Pharmaceutical Business Operations, Waters Division.

"We look forward to a fruitful collaboration with Waters Corporation" said Alastair Hill, Director and CTO at Dotmatics. "This agreement puts in place a framework to deliver novel software algorithms within the Waters MassLynx software platform which promises to result in huge time savings for scientists."